ReviewInternational journal of hematology2021

Monitoring minimal/measurable residual disease in B-cell acute lymphoblastic leukemia by flow cytometry during targeted therapy.

Zhiyu Liu et al.PubMed ↗Publisher ↗

No numbers read from the abstract.